Neurochemistry International is a peer-reviewed scientific journal covering research in neurochemistry, including molecular and cellular neurochemistry, neuropharmacology and genetic aspects of central nervous system function, neuroimmunology, metabolism as well as the neurochemistry of neurological and psychiatric disorders of the CNS. It is published by Elsevier and the editor-in-chief is Michael Robinson (Children's Hospital of Philadelphia). According to the Journal Citation Reports, the journal has a 2021 impact factor of 4.297.[1]
| Discipline | Neuroscience |
|---|---|
| Language | English |
| Edited by | Michael Robinson |
| Publication details | |
| Publisher | |
| Frequency | 10/year |
| 4.297 (2021) | |
| Standard abbreviations | |
| ISO 4 | Neurochem. Int. |
| Indexing | |
| CODEN | NEUIDS |
| ISSN | 0197-0186 (print) 1872-9754 (web) |
| OCLC no. | 05937082 |
| Links | |
References
edit- ^ "Neurochemistry International". 2021 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2021.
External links
edit
  | This article about a neuroscience journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
.svg){kind=small} | This article about a biochemistry journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |